Skip to main content
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 4/2017

03.02.2017 | Reports of Original Investigations

A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery

verfasst von: David Neville Levin, MD, MSc, BESc (Mech), Zachary Dulberg, MD, An-Wen Chan, D.Phil, Gregory M. T. Hare, PhD, C. David Mazer, MD, Aaron Hong, MD

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Nabilone is a synthetic cannabinoid with properties that make it an appealing candidate as a postoperative nausea and vomiting (PONV) prophylactic adjunct. Nabilone has proven clinical utility in chemotherapy-related nausea and vomiting but has not been adequately tested for PONV. The purpose of this study was to evaluate the effectiveness of a single dose of nabilone for the prevention of PONV.

Methods

This was a pragmatic single-centre randomized-controlled trial comparing oral nabilone vs placebo for the prevention of PONV. Eligible patients scheduled for elective surgery under general anesthesia who had a preoperative risk of PONV greater than 60% received either nabilone 0.5 mg or placebo orally prior to surgery. As part of the pragmatic design, the study medication was given in addition to any other combination of antiemetic prophylaxis. The primary outcome was the incidence of PONV. Secondary outcomes included the effect on pain, speed of recovery, and drug side effects.

Results

Of the 340 patients randomized, 172 received nabilone and 168 received placebo. There was no difference in the incidence of PONV, which occurred in 20.9% in the nabilone group and 21.4% in the placebo group (relative risk, 0.98; 95% confidence interval, 0.89 to 1.11; P = 0.99). There were also no differences in pain scores, opioid consumption, or reported drug side effects.

Conclusion

Oral nabilone 0.5 mg given as a single dose prior to surgery is ineffective in reducing PONV. This trial was registered at ClinicalTrials.gov, identifier: NCT02115529.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91: 693-700.CrossRefPubMed Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91: 693-700.CrossRefPubMed
3.
Zurück zum Zitat Fortier J, Chung F, Su J. Unanticipated admission after ambulatory surgery–a prospective study. Can J Anaesth 1998; 45: 612-9.CrossRefPubMed Fortier J, Chung F, Su J. Unanticipated admission after ambulatory surgery–a prospective study. Can J Anaesth 1998; 45: 612-9.CrossRefPubMed
4.
Zurück zum Zitat Dzwonczyk R, Weaver TE, Puente EG, Bergese SD. Postoperative nausea and vomiting prophylaxis from an economic point of view. Am J Ther 2012; 19: 11-5.CrossRefPubMed Dzwonczyk R, Weaver TE, Puente EG, Bergese SD. Postoperative nausea and vomiting prophylaxis from an economic point of view. Am J Ther 2012; 19: 11-5.CrossRefPubMed
5.
Zurück zum Zitat Gupta D, Haber H. Emetogenicity-risk procedures in same day surgery center of an academic university hospital in United States: a retrospective cost-audit of postoperative nausea vomiting management. Middle East J Anaesthesiol 2014; 22: 493-502.PubMed Gupta D, Haber H. Emetogenicity-risk procedures in same day surgery center of an academic university hospital in United States: a retrospective cost-audit of postoperative nausea vomiting management. Middle East J Anaesthesiol 2014; 22: 493-502.PubMed
6.
Zurück zum Zitat Parra-Sanchez I, Abdallah R, You J, et al. A time-motion economic analysis of postoperative nausea and vomiting in ambulatory surgery. Can J Anesth 2012; 59: 366-75.CrossRefPubMed Parra-Sanchez I, Abdallah R, You J, et al. A time-motion economic analysis of postoperative nausea and vomiting in ambulatory surgery. Can J Anesth 2012; 59: 366-75.CrossRefPubMed
7.
Zurück zum Zitat Doggrell SA, Hancox JC. Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia. Expert Opin Drug Saf 2013; 12: 421-31.CrossRefPubMed Doggrell SA, Hancox JC. Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia. Expert Opin Drug Saf 2013; 12: 421-31.CrossRefPubMed
8.
Zurück zum Zitat Spevak C, Hamsher C, Brown CQ, Wedam EF, Haigney MC. The clinical significance of QT interval prolongation in anesthesia and pain management: what you should and should not worry about. Pain Med 2012; 13: 1072-80.CrossRefPubMed Spevak C, Hamsher C, Brown CQ, Wedam EF, Haigney MC. The clinical significance of QT interval prolongation in anesthesia and pain management: what you should and should not worry about. Pain Med 2012; 13: 1072-80.CrossRefPubMed
9.
Zurück zum Zitat Beaulieu P, Boulanger A, Desroches J, Clark AJ. Medical cannabis: considerations for the anesthesiologist and pain physician. Can J Anesth 2016; 63: 608-24.CrossRefPubMed Beaulieu P, Boulanger A, Desroches J, Clark AJ. Medical cannabis: considerations for the anesthesiologist and pain physician. Can J Anesth 2016; 63: 608-24.CrossRefPubMed
10.
Zurück zum Zitat Sharkey KA, Darmani NA, Parker LA. Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol 2014; 722: 134-46.CrossRefPubMed Sharkey KA, Darmani NA, Parker LA. Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol 2014; 722: 134-46.CrossRefPubMed
11.
Zurück zum Zitat Tramer MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 2001; 323: 16-21.CrossRefPubMedPubMedCentral Tramer MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 2001; 323: 16-21.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ware MA, Daeninck P, Maida V. A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting. Ther Clin Risk Manag 2008; 4: 99-107.CrossRefPubMed Ware MA, Daeninck P, Maida V. A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting. Ther Clin Risk Manag 2008; 4: 99-107.CrossRefPubMed
13.
14.
Zurück zum Zitat Hsu ES. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am J Ther 2010; 17: 476-86.CrossRefPubMed Hsu ES. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am J Ther 2010; 17: 476-86.CrossRefPubMed
15.
Zurück zum Zitat Apfel CC, Heidrich FM, Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth 2012; 109: 742-53.CrossRefPubMed Apfel CC, Heidrich FM, Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth 2012; 109: 742-53.CrossRefPubMed
16.
Zurück zum Zitat Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA 1961; 178: 261-6.CrossRefPubMed Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA 1961; 178: 261-6.CrossRefPubMed
17.
Zurück zum Zitat Tricco AC, Soobiah C, Blondal E, et al. Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis. BMC Med 2015; 13: 136.CrossRefPubMedPubMedCentral Tricco AC, Soobiah C, Blondal E, et al. Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis. BMC Med 2015; 13: 136.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Jordan K, Hinke A, Grothey A, et al. A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis. Support Care Cancer 2007; 15: 1023-33.CrossRefPubMed Jordan K, Hinke A, Grothey A, et al. A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis. Support Care Cancer 2007; 15: 1023-33.CrossRefPubMed
19.
Zurück zum Zitat Myles PS, Wengritzky R. Simplified postoperative nausea and vomiting impact scale for audit and post-discharge review. Br J Anaesth 2012; 108: 423-9.CrossRefPubMed Myles PS, Wengritzky R. Simplified postoperative nausea and vomiting impact scale for audit and post-discharge review. Br J Anaesth 2012; 108: 423-9.CrossRefPubMed
20.
Zurück zum Zitat Chauny JM, Paquet J, Lavigne G, Marquis M, Daoust R. Evaluating acute pain intensity relief: challenges when using an 11-point numerical rating scale. Pain 2016; 157: 355-60.CrossRefPubMed Chauny JM, Paquet J, Lavigne G, Marquis M, Daoust R. Evaluating acute pain intensity relief: challenges when using an 11-point numerical rating scale. Pain 2016; 157: 355-60.CrossRefPubMed
21.
Zurück zum Zitat Aldrete JA. Modifications to the postanesthesia score for use in ambulatory surgery. Journal of perianesthesia nursing: official journal of the American Society of PeriAnesthesia Nurses / American Society of PeriAnesthesia Nurses 1998; 13: 148-55.CrossRef Aldrete JA. Modifications to the postanesthesia score for use in ambulatory surgery. Journal of perianesthesia nursing: official journal of the American Society of PeriAnesthesia Nurses / American Society of PeriAnesthesia Nurses 1998; 13: 148-55.CrossRef
22.
Zurück zum Zitat Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350: 2441-51.CrossRefPubMedPubMedCentral Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350: 2441-51.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Lewis IH, Campbell DN, Barrowcliffe MP. Effect of nabilone on nausea and vomiting after total abdominal hysterectomy. Br J Anaesth 1994; 73: 244-6.CrossRefPubMed Lewis IH, Campbell DN, Barrowcliffe MP. Effect of nabilone on nausea and vomiting after total abdominal hysterectomy. Br J Anaesth 1994; 73: 244-6.CrossRefPubMed
24.
Zurück zum Zitat Layeeque R, Siegel E, Kass R, et al. Prevention of nausea and vomiting following breast surgery. Am J Surg 2006; 191: 767-72.CrossRefPubMed Layeeque R, Siegel E, Kass R, et al. Prevention of nausea and vomiting following breast surgery. Am J Surg 2006; 191: 767-72.CrossRefPubMed
25.
Zurück zum Zitat Kleine-Brueggeney M, Greif R, Brenneisen R, Urwyler N, Stueber F, Theiler LG. Intravenous delta-9-tetrahydrocannabinol to prevent postoperative nausea and vomiting: a randomized controlled trial. Anesth Analg 2015; 121: 1157-64.CrossRefPubMed Kleine-Brueggeney M, Greif R, Brenneisen R, Urwyler N, Stueber F, Theiler LG. Intravenous delta-9-tetrahydrocannabinol to prevent postoperative nausea and vomiting: a randomized controlled trial. Anesth Analg 2015; 121: 1157-64.CrossRefPubMed
26.
Zurück zum Zitat Einhorn L. Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy. Cancer Treat Rev 1982; 9 Suppl B: 55-61. Einhorn L. Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy. Cancer Treat Rev 1982; 9 Suppl B: 55-61.
27.
Zurück zum Zitat Jones SE, Durant JR, Greco FA, Robertone A. A multi-institutional phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting. Cancer Treat Rev 1982; 9 Suppl B: 45-8. Jones SE, Durant JR, Greco FA, Robertone A. A multi-institutional phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting. Cancer Treat Rev 1982; 9 Suppl B: 45-8.
28.
Zurück zum Zitat Levitt M. Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients. Cancer Treat Rev 1982; 9 Suppl B: 49-53. Levitt M. Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients. Cancer Treat Rev 1982; 9 Suppl B: 49-53.
29.
Zurück zum Zitat Wada JK, Bogdon DL, Gunnell JC, Hum GJ, Gota CH, Rieth TE. Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy. Cancer Treat Rev 1982; 9 Suppl B: 39-44. Wada JK, Bogdon DL, Gunnell JC, Hum GJ, Gota CH, Rieth TE. Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy. Cancer Treat Rev 1982; 9 Suppl B: 39-44.
30.
Zurück zum Zitat Valeant Canada Limitée/Limited. Product monograph, Nabilone; submission control no: 124406. 2009. Available from URL: http://www.editorialmanager.com/caan/download.aspx?id=90945&guid={A1DB26F5-FE4C-49F7-AA37-99FB10C2E271}&scheme=1 (accessed November 2016). Valeant Canada Limitée/Limited. Product monograph, Nabilone; submission control no: 124406. 2009. Available from URL: http://​www.​editorialmanager​.​com/​caan/​download.​aspx?​id=​90945&​guid=​{A1DB26F5-FE4C-49F7-AA37-99FB10C2E271}&scheme=1 (accessed November 2016).
31.
Zurück zum Zitat Wang XX, Zhou Q, Pan DB, et al. Dexamethasone versus ondansetron in the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a meta-analysis of randomized controlled trials. BMC Anesthesiol 2015; 15: 118.CrossRefPubMedPubMedCentral Wang XX, Zhou Q, Pan DB, et al. Dexamethasone versus ondansetron in the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a meta-analysis of randomized controlled trials. BMC Anesthesiol 2015; 15: 118.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Woodhams SG, Sagar DR, Burston JJ, Chapman V. The role of the endocannabinoid system in pain. Hand Exp Pharmacol 2015; 227: 119-43.CrossRef Woodhams SG, Sagar DR, Burston JJ, Chapman V. The role of the endocannabinoid system in pain. Hand Exp Pharmacol 2015; 227: 119-43.CrossRef
33.
Zurück zum Zitat Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 2001; 323: 13-6.PubMed Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 2001; 323: 13-6.PubMed
Metadaten
Titel
A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery
verfasst von
David Neville Levin, MD, MSc, BESc (Mech)
Zachary Dulberg, MD
An-Wen Chan, D.Phil
Gregory M. T. Hare, PhD
C. David Mazer, MD
Aaron Hong, MD
Publikationsdatum
03.02.2017
Verlag
Springer US
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 4/2017
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-017-0814-3

Weitere Artikel der Ausgabe 4/2017

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 4/2017 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.